Talk:Troglitazone

This is the talk page for discussing improvements to the Troglitazone article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Troglitazone.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Four Stereoisomers

Two stereocenters are found in Troglitazone. Thus, four stereoisomers may exist: (S,S), (R,R), (S,R), and (R,S). Is this active ingredient a mixture of all four stereoisomers or just a mixture of (S,S) and (R,R)? It could be also a mixture of (S,R) and (R,S) or even a pure (which?) stereoisomer. --Jü (talk) 19:26, 19 September 2009 (UTC)[reply]